Navigation Links
Rapid Fire Marketing: Medical Cannabis Management Cleared for Medical Cannabis Cultivation
Date:4/11/2011

CARSON CITY, Nev., April 11, 2011 /PRNewswire/ -- Rapid Fire Marketing (Pink Sheets: RFMK) announced today that their wholly owned subsidiary, Medical Cannabis Management (MCM), has been cleared through all legal channels to begin cultivation and growing of medical cannabis. Management of MCM believes that this new division of the Company's business will significantly increase revenue and earnings through 2011 and beyond. This represents a substantial and considerable income stream which the Company expects to realize within just a few months.

With the passing of Proposition 215, making medical cannabis legal in the state of California, Rapid Fire Marketing through MCM has entered the business of providing full service marketing, consulting and management services to this newly emerged industry, which will now include cultivation of medical cannabis. Rapid Fire Marketing is positioned to handle the demand of services needed by this new generation of small business entrepreneurs, with plans to capitalize on this exploding industry and generate revenue through service management contracts. Additional information can be found at http://www.medicalcannabismanagement.com.

"Needless to say, the legal ability to cultivate and grow medical cannabis would add a substantial amount of revenue to our business. We are in the process of finalizing details on the logistics of this new division of our business and we expect to be up and running by early summer," a Company spokesperson stated.

Contact@MedicalCannabisManagement.com

Safe Harbor:

From time to time, the Company may issue news releases that contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. For those statements, the Company claims the protection of the safe harbor for forward-looking statement provisions contained in the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be "forward-looking statements." "Forward-looking statements" are based upon expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those anticipated.


'/>"/>
SOURCE Rapid Fire Marketing
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
2. Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad
3. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
4. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
5. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
6. Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
7. Reprints Desk Bolsters Ultra-Rapid Document Delivery Service Through New Electronic Sourcing Agreement with the American Medical Association, Publisher of JAMA & Archives Journals
8. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
9. Marken Rapidly Responds to Global Supply Chain Security Measures
10. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
11. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):